Aptinyx (APTX) Appoints Gilmore O’Neill to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to Aptinyx (APTX) Appoints Gilmore O’Neill to its Board

Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors

October 20, 2021 7:57 AM EDT

EVANSTON, Ill.--(BUSINESS WIRE)-- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced the appointment of Gilmore ONeill, M.B., M.M.Sc., to the companys board of directors. Dr. ONeill currently serves as chief medical officer and executive vice president of research and development at Sarepta Therapeutics.

Gilmore brings an exceptional background of experience and leadership to the Aptinyx board of directors, said Norbert Riedel, Ph.D., chief executive officer of Aptinyx. His expertise in research and clinical... More